Clik here to view.
Ultraviolet A more cancer-causing than once thought
While the evidence linking sunbeds to the development of skin cancer continues to mount, recent research provides new insight into the underlying mechanisms. Radiation from both the sun and tanning...
View ArticleClik here to view.
EPP results and clinical relevance
A protoporphyrin IX molecule Over recent months I have written several times of the need for Clinuvel to prove clinical relevance in our trials with the use of SCENESSE® (afamelanotide) in...
View ArticleClik here to view.
Low sunscreen use, high melanoma rates: a breakdown of the sunsmart message?
It’s estimated that more than 9,000 Americans will die from melanoma this year and 76,000 new cases of the disease will be diagnosed. Melanoma, an aggressive skin cancer which can spread (metastasize)...
View ArticleClik here to view.
MAA: a moment in Clinuvel’s EPP story
Those who have taken an interest in Clinuvel will have learned with joy that, on Monday February 6th, the company announced its first official filing for SCENESSE® (afamelanotide) with the European...
View ArticleClik here to view.
Top five sun and skin myths (part 2)
Myth 4: I need lots of sun exposure to create vitamin D Vitamin D is a contentious topic in modern medicine and something we’ve blogged about regularly. It’s known to play a role in strengthening bones...
View ArticleClik here to view.
Too rare to diagnose: Hydroa Vacciniforme
We recently invited Richard Roosenboom to share his experiences as a parent of a child with a rare disease. In the coming weeks we will publish part of the Roosenboom’s story in a four post series....
View ArticleClik here to view.
Hang in there! Take back control! (Part 1)
We recently invited Richard Roosenboom to share his experiences as a parent of a child with a rare disease. In the coming weeks we will publish part of the Roosenboom’s story in a four post series. You...
View ArticleClik here to view.
Hang in there! Take back control! (Part 2)
We recently invited Richard Roosenboom to share his experiences as a parent of a child with a rare disease. In the coming weeks we will publish part of the Roosenboom’s story in a four post series. In...
View ArticleClik here to view.
Living with HV
In the final post from the Roosenboom family, and to help recognise Rare Diseases Day, Simone has penned her own piece on her experiences with Hydroa Vacciniforme. We are grateful to the Roosenboom...
View ArticleClik here to view.
Inside Clinuvel: effective drug development
Take ten years, half a billion dollars and countless man hours from some of the most highly trained, intelligent individuals on the globe. You still stand a 90% chance of failure, some of which is...
View Article
